JVLCX | VIVIX | JVLCX / VIVIX | |
Total Expense Ratio | 1.71 | 0.04 | 4,275% |
Annual Report Gross Expense Ratio | 1.72 | 0.04 | 4,300% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | 8.290 | 6.533 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.1B | 196B | 9% |
Annual Yield % from dividends | 0.02 | 2.19 | 1% |
Returns for 1 year | -2.63 | 7.91 | -33% |
Returns for 3 years | 5.68 | 25.93 | 22% |
Returns for 5 years | 31.04 | 68.54 | 45% |
Returns for 10 years | 25.98 | 114.61 | 23% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IZRL | 27.19 | 0.17 | +0.63% |
ARK Israel Innovative Technology ETF | |||
IBDQ | 25.14 | 0.02 | +0.08% |
iShares iBonds Dec 2025 Term Corp ETF | |||
DIEM | 31.08 | -0.01 | -0.04% |
Franklin Emerging Mkt Core Div TltIdxETF | |||
AOCT | 25.99 | -0.01 | -0.04% |
Innovator Eq Dfnd Prt ETF - 2YrtoOct2026 | |||
SIXJ | 32.71 | -0.04 | -0.13% |
AllianzIM US Lrg Cp 6M Bfr10 Jan/Jul ETF |